Azelastine Hydrochloride
Product Images NDC 53002-5279

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Azelastine Hydrochloride (NDC 53002-5279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Azelastine Fig1)

An instructional illustration showing components of a nasal spray device labeled as Dust Cover, Spray Pump Unit with "Shoulders," Safety Clip, and Bottle, associated with AZELASTINE HYDROCHLORIDE nasal spray.*

FDA Label Image

Figure B (Azelastine Fig2)

An instructional diagram labeled Figure B, depicting a two-step process with hands manipulating a bottle. The first step shows one hand holding the bottle with an arrow pointing upward, indicating removal or lifting of the cap or applicator. The second step shows the other hand holding a small syringe or dropper, positioned horizontally with an arrow pointing forward, suggesting preparation or removal from the main bottle.*

FDA Label Image

Figure C (Azelastine Fig3)

An instructional diagram showing proper use of a nasal spray bottle. It depicts a hand holding the bottle with the index finger pressing down on the nozzle to spray the medication, indicated by an arrow pointing down and spray lines from the nozzle. The image is labeled as Figure C.*

FDA Label Image

Figure D (Azelastine Fig4)

An instructional line drawing labeled Figure D shows a person using a nasal spray bottle, with the spray tip inserted into one nostril. The person's head is slightly tilted back and the hand is holding the spray bottle upright.*

FDA Label Image

Figure E (Azelastine Fig5)

An instructional line drawing showing a person using a nasal spray. The individual holds the spray bottle with one hand while inserting the nozzle into one nostril, using the other hand to slightly close the opposite nostril. Below the image is the label "Figure E."*

FDA Label Image

Figure F And Figure G (Azelastine Fig6)

Instructional illustrations showing two steps for using a nasal spray. Figure F depicts a person holding the spray bottle and pressing down the nozzle to release the spray. Figure G shows a person holding the bottle horizontally and spraying fluid, with droplets visible that suggest proper spray action.*

FDA Label Image

Chemical Structure (Azelastine Str)

Chemical structure of azelastine hydrochloride displaying its molecular framework including chlorophenyl, benzodiazepine rings, and methylpiperazine hydrochloride groups as depicted in the diagram.*

FDA Label Image

Label Image (Lbl530025279)

AZELASTINE HYDROCHLORIDE 30 mL nasal spray bottle label from RPK Pharmaceuticals, Inc. The label specifies a 30 mL bottle with 137 mcg per actuation (200 doses) of azelastine HCl nasal spray. It includes directions for use, storage instructions, lot number, expiration date, and space for patient and prescriber information. The label is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.